
Adrienne Rivlin, Partner, L.E.K. Consulting
Advertisement

Dr. Adrienne Rivlin is a partner in L.E.K.’s Healthcare practice, based in the London office. She advises private and public sector organisations across the pharmaceutical, biotech, medical device and consumer healthcare sectors on their critical commercial challenges, including corporate and portfolio strategy development; product launch; pricing and market access; clinical governance structures and processes; and commercial and regulatory due diligence.
Email: a.rivlin@lek.com
Articles by Adrienne Rivlin, Partner, L.E.K. Consulting

Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on PharmExec
1
AstraZeneca Shares Drop Following Wainua’s Failed Heart Disease Trial
2
U.S. Supreme Court Weighs Inducement Liability Beyond FDA Carve-Out Labels
3
Pharma M&A Roundup: Chemomab Therapeutics Enters Merger Agreement with Scipher Medicine, Teva and Polpharma Biologics Enter Global Licensing Agreement
4
Novartis to Layoff 322 NJ Employees: Report
5